Rezulin Resources and Support

These sites and sources online may help you learn more about rezulin, liver damage attributable to rezulin, dealing with liver damage, and more.

American Diabetes Association: http://www.diabetes.org
This Web site represents the National non-profit organization and provides information on diabetes, diabetes medicines and diabetes issues in the news.
American Liver Foundation: http://www.liverfoundation.org
The Web site for the American Liver Foundation, the only national, voluntary non-profit health agency dedicated to preventing, treating and curing hepatitis and all liver diseases through research, education and support groups.; 75 Maiden Lane, Suite 603
New York, NY 10038
1-800-GO LIVER (465-4837)
Diabetes.com: http://www.diabetes.com
Sponsored by PlanetRX, an on-line pharmacy, the Diabetes.com Web site provides information on current diabetes issues, products and prescriptions.
International Diabetes Center: http://www.idcdiabetes.com
This Web site is sponsored by the Institute for Research and Education at the HealthSystem Minnesota. It provides medical information on diabetes and the programs associated with it.
Joslin Diabetes Center: http://www.joslin.org
This Web site is sponsored by Joslin Medical Center, an affiliate of Harvard Medical School. It offers diabetes news, research and education information.
National Foundation for Transplants: http://www.transplants.org
This Web site provides information on programs for healthcare and financial funding for organ transplant candidates. Financial Assistance Information: 1-800-489-3863
National Institute of Diabetes and Digestive and Kidney Diseases: http://www.niddk.nih.gov
The foundation supports research on diabetes and other diseases and provides easy-to-read information here.
TransWeb: http://www.transweb.org
This Web site for the TransWeb non-profit organization provides information about organ transplantation and donation.
Warner Lambert/Parke-Davis Drug Information Services: http://www.rezulin.com
The manufacturer of Rezulin's information Web site with information on its removal from the market. For additional information, contact Warner Lamber/Parke-Davis at 1-800-223-0432.

Rezulin News Timeline

1997: January - Rezulin is approved by the FDA to treat Type II diabetes.; November - The FDA issues a warning about Rezulin (troglitazone). Recommended prescribing information is changed by the drug's manufacturer; new warning label information is added.; December - Approximately 150 adverse events associated with Rezulin have been reported to the FDA.
1998: June - The FDA and Rezulin manufacturer Parke-Davis agree to again tighten restrictions on the use of Rezulin.; July - Parke-Davis sends a letter to heathcare professionals warning to test for liver abnormalities and updating them on the changes in recommended use.
2001: March - Resulin sales are discontinued.

Contact Us

This information © 2002-2010 by the Drug Exposure Lawyers at Goldberg, Persky, & White, P.C. The content of this web site was developed as a service to mesothelioma patients and their families. Web site content has not been prepared or endorsed by physicians or licensed medical professionals. Nothing on this site should be taken as medical advice. Our staff are not physicians nor trained medical professionals and nothing they say should be taken as medical advice. The purpose of this site is to provide patients and their families with useful information and access to resources which may be helpful. Patients are encouraged to consult with their physician for medical advice and with an mesothelioma attorney for legal advice.

Last Updated: May 12, 2010. 12:03:34 pm.